Mannosidase Deficiency Diseases clinical trials
The registry lists 5 studies for Mannosidase Deficiency Diseases across 4 countries. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2023-09-15. Counting its narrower condition alpha-Mannosidosis too: 27 studies, 5 open.
Status
- Completed
- 2
- Withdrawn
- 2
- Status unknown
- 1
Who runs them
Masonic Cancer Center, University of Minnesota (1) · University of Florida (1) · Fairview University Medical Center (1) · Chiesi Farmaceutici S.p.A. (1) · CENTOGENE GmbH Rostock (1)
What is being tested here
Drugs under test in Mannosidase Deficiency Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Busulfan | 0 | 0 | 1 |
| Cyclophosphamide | 0 | 0 | 1 |
| Antilymphocyte Serum | 0 | 0 | 1 |
| Velmanase alfa | 0 | 1 | 1 |
Who these studies take
No Mannosidase Deficiency Diseases study is recruiting now.
Across all 5 studies, recruiting or not: 20% stop at 75 or younger and 20% at 65; 100% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. search them.
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell TransplantationCompletedNCT03513328Phase 1/21 country
- Biomarker for Mannosidosis Disease (BioMannosidosis)WithdrawnNCT032640403 countries
- Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha MannosidosisWithdrawnNCT04031066Phase 3
- Stem Cell Transplantation for HurlerCompletedNCT00176917Phase 21 country
- Study of Pulmonary Complications in Pediatric Patients With Storage Disorders Undergoing Allogeneic Hematopoietic Stem Cell TransplantationStatus unknownNCT000059001 country